The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
Abstract
Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia. The purpose of this statement is to examine new evidence on the association of lipid abnormalities with early atherosclerosis, discuss challenges with previous guidelines, and highlight results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterolemia. Recommendations are provided to guide decision-making with regard to patient selection, initiation, monitoring, and maintenance of drug therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, there are data to suggest that care for T1D has improved as evidenced by reduced rates of microvascular disease in the past decades109–111, whereas data on CVD suggest that substantially less progress has been made in reduction of macrovascular disease rates111–113.”
From Epidemiology of type 1 diabetes (2010) · cites this paper as [112]
In the citing paper
“the AHA categorizes type 1 children in the highest tier for cardiovascular risk and recommends both lifestyle and pharmacologic treatment for those with elevated LDL cholesterol levels (285,286).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [286]
Citations
Cites
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
Freedman, D. S., Dietz, W. H., Srinivasan, S. R., & Berenson, G. S. (1999) · Pediatrics · doi:10.1542/peds.103.6.1175 · Cited by 2,456
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
Overweight in Children and Adolescents
Daniels, S. R., Arnett, D. K., Eckel, R. H., Gidding, S. S., Hayman, L. L., Kumanyika, S., Robinson, T. N., Scott, B. J., Jeor, S. S., & Williams, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000161369.71722.10 · Cited by 1,543
Self-citationKrotkiewski, M., Björntorp, P. A., Sjöström, L., & Smith, U. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111040 · Cited by 1,475
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Flagged first, then by citations
Research works printed but not linked: 13
- 10.1161/atvb.15.9.1512 · DOI
- 10.1161/circ.89.5.8181179 · DOI
- 10.1161/circ.103.11.1546 · DOI
- 10.1161/circ.103.22.2705 · DOI
- 10.1161/circ.104.23.2815 · DOI
- 10.1161/atvb.16.8.984 · DOI
- 10.1161/atvb.20.9.2070 · DOI
- 10.1161/circ.101.13.1533 · DOI
- 10.1161/hyp.26.6.984 · DOI
- 10.1016/S0891-5245(02)06571-9 · DOI
- Firth JC, Marais AD, Byrnes P, Fusco RA, Bonnici F. Fluvastatin in heterozygous familial hypercholesterolemia. Cardiol Young. 2000; 10 (suppl 2): 35. Abstract.
- 10.1161/circ.102.13.1477 · DOI
- 10.1161/circ.94.6.1386 · DOI
Cited by
Sorted by citations
Items 201–300 of 418
Hayman, L. L. (2010) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181cec6ba · Cited by 15
Self-citationGirardet, J.-P., Luc, G., Rieu, D., Bruckert, É., Darmaun, D., & Farnier, M. (2010) · Archives de Pédiatrie · doi:10.1016/j.arcped.2010.10.017 · Cited by 15
Disorders of Lipoprotein Metabolism
Hegele, R. A., & Tonstad, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-40337-8_43 · Cited by 15
Benefits of the MEDPED treatment support program for patients with familial hypercholesterolemia
Stephenson, S., Larrinaga‐Shum, S., & Hopkins, P. N. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.02.004 · Cited by 15
Lipid concentrations in children and adolescents: it is not all about obesity
Daniels, S. R. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022483 · Cited by 15
Self-citationNon-HDL-cholesterol in an adolescent diabetes population
Kuryan, R., Jacobson, M. S., & Frank, G. R. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.006 · Cited by 14
Self-citationA comparison of European and US guidelines for familial hypercholesterolaemia
Reiner, Ž. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000178 · Cited by 14
Adolescent obesity: etiology, office evaluation, and treatment.
Peebles, R. (2008) · PubMed · Cited by 13
Heterogeneidade do diabetes melito tipo 1
Dib, S. A. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200008 · Cited by 15
Vuorio, A. F., & Kovanen, P. T. (2018) · Nutrients · doi:10.3390/nu10121842 · Cited by 14
2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
Lim, J. S., Kim, E. Y., Kim, J. H., Yoo, J. H., Yi, K. H., Chae, H. W., Choi, J., Kim, J. Y., & Hwang, I. T. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.01340 · Cited by 14
Encouraging appropriate treatment for familial hypercholesterolemia
Hopkins, P. N. (2010) · Clinical Lipidology · doi:10.2217/clp.10.22 · Cited by 14
Kolovou, G. D., Vasiliadis, I. K., Gontoras, N., Kolovou, V., & Hatzigeorgiou, G. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12105 · Cited by 13
Cardiac status of perinatally HIV-infected children
Williams, P. L., Correia, K. F. B., Karalius, B., Dyke, R. B. V., Wilkinson, J. D., Shearer, W. T., Colan, S. D., & Lipshultz, S. E. (2018) · AIDS · doi:10.1097/qad.0000000000001988 · Cited by 13
Hatami, M., Tohidi, M., Mohebi, R., Khalili, D., Azizi, F., & Hadaegh, F. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-107 · Cited by 12
The role of dyslipidemia in sensorineural hearing loss in children
Anbari, S., Isazadeh, D., Safavi, A., Alaie, M., & Azizi, F. (2009) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2009.10.003 · Cited by 12
de Castro, P. S. G. C. A., & Oliveira, F. L. C. (2009) · Jornal de Pediatria · doi:10.2223/jped.1852 · Cited by 12
Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes
SHAH, A. S., Dolan, L. M., Dabelea, D., Stafford, J. M., D'Agostino, R. B., Mayer‐Davis, E. J., Marcovina, S. M., Imperatore, G., Wadwa, R. P., Daniels, S. R., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12162 · Cited by 12
Self-citationSoy-derived Isoflavones Treatment in Children with Hypercholesterolemia: A Pilot Study
Zung, A., Shachar, S., Zadik, Z., & Kerem, Z. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.1-2.133 · Cited by 12
Management of familial hypercholesterolaemia in children and adolescents
Justo, R. N. (2011) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2011.02206.x · Cited by 11
Treatment of dyslipidaemia in childhood
Kusters, D. M., Vissers, M. N., Wiegman, A., Kastelein, J. J. P., & Hutten, B. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003592169 · Cited by 11
Noto, N., Okada, T., Abe, Y., Miyashita, M., Kanamaru, H., Karasawa, K., Ayusawa, M., Sumitomo, N., & Mugishima, H. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.12.026 · Cited by 11
Microalbuminuria and Heart Rate Variability in Adolescents With Diabetes
Faulkner, M. S., Quinn, L., & Fritschi, C. (2009) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2009.01.002 · Cited by 11
The Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years
Gooding, H. C., & Johnson, H. M. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0509-2 · Cited by 11
Viner, R., Kinra, S., Christie, D., Cole, T. J., Costa, S., Croker, H. A., Fry, T., Hsia, Y., Hudson, L. D., Kessel, A. S., et al. (2020) · Programme Grants for Applied Research · doi:10.3310/pgfar08030 · Cited by 12
Maternal Heterozygous Familial Hypercholesterolemia and Its Consequences for Mother and Child
Rutherford, J. D. (2011) · Circulation · doi:10.1161/circulationaha.111.059311 · Cited by 11
Challenges of Existing Pediatric Dyslipidemia Guidelines
Steinberger, J., & Kelly, A. S. (2008) · Circulation · doi:10.1161/circulationaha.107.743104 · Cited by 11
Self-citationDaniels, S. R. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.2315 · Cited by 11
Self-citationMetabolic syndrome and dyslipidemia in youth
McNeal, C. J., & Wilson, D. P. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.04.005 · Cited by 10
Krebs, A., Doerfer, J., Krause, A., Grulich‐Henn, J., Holder, M., Hecker, W., Lichte, K., Schmidt‐Trucksäss, A., Winkler, K., & Schwab, K. O. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0365 · Cited by 10
Sztam, K. A., Jiang, H., Jurgrau, A., Deckelbaum, R. J., & Foca, M. D. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181f5e9d4 · Cited by 10
Lipid Disorders in Children and Adolescents
Daniels, S. R., & Couch, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00025-7 · Cited by 10
Self-citationDyslipidemia in Children and Adolescents: Current Insights and Updated Treatment Approaches
Kim, S. E. (2025) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2025.28.3.148 · Cited by 9
Management of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 9
Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina
Araujo, M. L. G., & Zerbino, M. C. (2022) · Value in Health Regional Issues · doi:10.1016/j.vhri.2022.08.009 · Cited by 9
Iftikhar, S., Bond, A., Wagan, A. I., Weinberg, P. D., & Bharath, A. A. (2011) · International Journal of Biomedical Imaging · doi:10.1155/2011/270247 · Cited by 9
Rocco, C. A., Mecikovsky, D., Aulicino, P. C., Bologna, R., Sen, L., & Mangano, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039678 · Cited by 9
Wharf, C., & London, E. (2012) · Cited by 9
Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome
Zhang, Y., Zhou, J., Zheng, W., Lan, Z., Huang, Z., Yang, Q., Liu, C., Gao, R., & Zhang, Y. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0254-z · Cited by 9
McKenney, J. M., Ganz, P., Wiggins, B. S., & Saseen, J. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50026-3 · Cited by 10
Nutritional Management in Type 1 Diabetes Mellitus
Markovic-Jovanovic, S. R. (2013) · InTech eBooks · doi:10.5772/52465 · Cited by 7
Morbid obesity in a child with monosomy 1p36 syndrome
Zagalo, A., Dias, P., Pereira, C., & Sampaio, M. D. L. (2012) · BMJ Case Reports · doi:10.1136/bcr.01.2012.5503 · Cited by 8
Кislyak, O. A., Leontyeva, I. V., Starodubova, A. V., Alersandrov, A. A., Bubnova, M. G., Varaeva, Y. R., Асхатовна, К. А., Kozlova, L. V., Pavlovskaya, E. V., Polunina, D. A., et al. (2023) · Eurasian heart journal · doi:10.38109/2225-1685-2023-3-6-35 · Cited by 8
Flechtner‐Mors, M., Wiegand, S., Gellhaus, I., Siefken-Kaletka, H., Widhalm, K., Reinehr, T., Roost, H.-P., Leipold, G., Hoffmeister, U., Holl, R. W., et al. (2013) · Obesity Facts · doi:10.1159/000353397 · Cited by 8
Traitement d’une hypercholestérolémie familiale homozygote par LDL-aphérèse chez un enfant de 4 ans
Lefort, B., Giraud, C., Saulnier, J.-P., Bott, L., Gambert, C., Sosner, P., & Hankard, R. (2009) · Archives de Pédiatrie · doi:10.1016/j.arcped.2009.08.007 · Cited by 8
Uso de estatinas durante la infancia
Ceballos, L. T., Angelín, B. P., & García, C. R. (2008) · Anales de Pediatría · doi:10.1157/13117712 · Cited by 8
Nader, N. S., & Kumar, S. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0066-2 · Cited by 8
Measures against Pediatric Metabolic Syndrome
Lee, Y. A., Shin, C. H., & Lim, J. S. (2010) · Journal of Korean Medical Association · doi:10.5124/jkma.2010.53.5.392 · Cited by 7
Hypercholesterolemia – A disease with expression since childhood
Espinheira, M. D. C., Vasconcelos, C., Medeiros, A. M., Alves, A. C., Bourbon, M., & Guerra, A. (2013) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.09.013 · Cited by 7
Cui, H., & Zhang, X. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0595 · Cited by 8
Impact of Increasing Adiposity in Hyperlipidemic Children
Miller, S., Manlhiot, C., Chahal, N., Cullen-Dean, G., Bannister, L., & McCrindle, B. W. (2008) · Clinical Pediatrics · doi:10.1177/0009922808315214 · Cited by 7
Self-citationIntensive statin therapy for Indians: Part-I. Benefits.
Enas, E. A., Pazhoor, H. C., Kuruvila, A. T., & Vijayaraghavan, K. (2011) · PubMed · Cited by 7
Micieta, V., Čeháková, M., & Tonhajzerová, I. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12090326 · Cited by 6
Pediatric dyslipidemias: Prescription medication efficacy and safety
Browne, B. A., & Vasquez, S. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.04.008 · Cited by 6
Beyond BMI: The Next Chapter in Childhood Obesity Management
Bridger, T., & Wareham, A. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0114-y · Cited by 6
Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment
McCrindle, B. W., & Manlhiot, C. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.04.006 · Cited by 6
Self-citationManagement Considerations for Lipid Disorders During Pregnancy
Tummala, L. S., Agrawal, A., & Lundberg, G. P. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00926-1 · Cited by 6
Lipoprotein and Lipid Metabolism
Hegele, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00100-2 · Cited by 8
Pharmacotherapy of Dyslipidemia
Nahari, M. H. (2024) · Springer eBooks · doi:10.1007/978-981-99-5683-8_52 · Cited by 6
Ware, W. R. (2010) · Cited by 6
Hypercholesterolemia in children and young adults—current management
Raal, F. J. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872185 · Cited by 6
Pathogenesis and Management of Dyslipidemia in Obese Children
McCrindle, B. W. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_14 · Cited by 6
Self-citationCardiovascular Disease (CVD) Limbo: How Soon and Low Should We Go to Prevent CVD in Diabetes?
Maahs, D. M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0078 · Cited by 6
Hyánek, J., Pehal, F., Dubská, L., Martiníková, V., Privarová, J., & Taborsky, L. (2014) · Journal of Nutritional Therapeutics · doi:10.6000/1929-5634.2014.03.01.1 · Cited by 5
Malnutrition Causing Neonatal Dyslipidemia
Fernandes, V. P. I., de Faria, E. C., Bellomo‐Brandão, M. A., & Nogueira, R. J. N. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611403007 · Cited by 5
Hipercolesterolemia – uma patologia com expressão desde a idade pediátrica
Espinheira, M. C., Vasconcelos, C., Medeiros, A. M., Alves, A. C., Bourbon, M., & Guerra, A. (2013) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.09.008 · Cited by 5
Joly, M., Pinto, J. M., Rondó, P. H. D. C., Rodrigues, R., Ferreira, J. L., Cavalcanti, J. D. S., Brígido, L. F. D. M., & Odloak, D. (2015) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2015.05.017 · Cited by 5
Diabetes tipo 2 en la infancia y adolescencia
Ros, P., & Barrio, R. (2009) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(09)71116-3 · Cited by 5
Viikari, J. S. A., Niinikoski, H., Raitakari, O. T., & Simell, O. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831b4685 · Cited by 5
Costs of managing conditions associated with obesity among Australian teenagers
Booth, M. L., Dobbins, T., Aitken, R. J., Denney‐Wilson, E., Hardy, L. L., Okely, A. D., George, J., SULLIVAN, D. R., & Cowell, C. T. C. T. (2009) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2009.01503.x · Cited by 5
Boxwell, D., Cao, K., & Chen, M. C. (2013) · Cited by 5
Familial Hypercholesterolemia: A Decade of Progress
Gidding, S. S. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.10.007 · Cited by 5
Oza, C. M., Khadilkar, A. V., Mondkar, S., Gondhalekar, K. M., & Khadilkar, V. V. (2022) · Endocrine · doi:10.1007/s12020-022-03259-6 · Cited by 4
Castaño, L. S. Á., Restrepo, A. E., Rueda, J. D. G., & Aguirre, C. C. (2012) · Perspectivas en Nutrición Humana · doi:10.17533/udea.penh.10288 · Cited by 4
Alteraciones lipídicas en la hipertensión arterial esencial
Milián, R. L., Sánchez, R. G., Alfonso, K. B., & Olivares, D. Y. R. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
The impact of obesity on cardiovascular structure and function: the fetal programming era
St‐Pierre, J. (2012) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s12931 · Cited by 4
Kubicky, R. A., Dunne, C., Nandi-Munshi, D., & Luca, F. D. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-16 · Cited by 4
Management of Coronary Artery Disease in South Asian Populations
Ahmed, E., & El-Menyar, A. A. (2015) · Angiology · doi:10.1177/0003319715585663 · Cited by 4
Diabetes tipo 2 en población pediátrica española: cifras, pronóstico y posibilidades terapéuticas
Barrio, R., & Ros, P. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.01.003 · Cited by 4
Lipid disorders in children and adolescents
Daniels, S. R., & Couch, S. C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00032-9 · Cited by 4
Self-citationLipoprotein and Lipid Metabolism
Hegele, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00007-8 · Cited by 6
Dhuper, S., Sakowitz, S., Daniels, J., Buddhe, S., & Cohen, H. W. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2009.00056.x · Cited by 4
Midyett, L. K., Grunt, J., & Simon, S. D. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.6.531 · Cited by 4
Lipid abnormalities in children: should we be doing more?
Ayer, J. G., SULLIVAN, D. R., & Sholler, G. F. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02304.x · Cited by 4
A Pediatric Perspective: Adult problems in kids, new challenges in pediatric diabetes
Maahs, D. M., & Daniels, S. R. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00353.x · Cited by 4
Self-citationMalavskaiya, S. I., Lebedev, A. V., Николаевна, К. Г., Torshin, I. Y., & Громова, О. А. (2021) · Экология человека · doi:10.33396/1728-0869-2021-2-47-56 · Cited by 3
Myopathy in Statin-Treated Children and Adolescents: A Practical Approach
Kavey, R.-E. W. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01239-x · Cited by 3
Araújo, R. S., Ramos, A. D. P. S., & Borges, M. D. A. S. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000800012 · Cited by 3
Maldonado, V., Weeks, B. P., Cho, M., Turpin, D., & Arévalo, A. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2022.101518 · Cited by 3
Type 1 Diabetes Mellitus and Dyslipidemia
Maahs, D. M., & Eckel, R. H. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_7 · Cited by 3
Cholesterol Screening in an At-Risk Pediatric Population
O'Grady, M. J., Brown, A.-M., & O‘Neill, M. F. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9167-y · Cited by 3
NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice?
Watts, G. F., Hamilton‐Craig, I. R., & SULLIVAN, D. R. (2009) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.10.012 · Cited by 3
Approaches to dyslipidemia treatment in children and adolescents
Iughetti, L., Predieri, B., Bruzzi, P., & Balli, F. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.5.615 · Cited by 3
Assessment of atherosclerotic cardiovascular risk and management of dyslipidemia in obese children
Raghuveer, G. (2008) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2008.05.005 · Cited by 3
Reporting of dietary control frameworks in studies on simvastatin efficacy.
Somerset, S. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.10.005 · Cited by 3
Dyslipidémies de l’enfant et risque cardiovasculaire
Girardet, J.-P. (2009) · Archives de Pédiatrie · doi:10.1016/s0929-693x(09)74114-4 · Cited by 3
Hypercholesterolemia in Childhood
Iughetti, L., Predieri, B., & Bruzzi, P. (2015) · InTech eBooks · doi:10.5772/59760 · Cited by 3
Epidemiology of Type 2 Diabetes
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816080536121120101 · Cited by 3
Statin Prescription Rates in Children With Severe Dyslipidemia in the United States
Umapathi, K. K., & Thavamani, A. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.06.057 · Cited by 3
Hypertension in children with intellectual disabilities: a population not to be overseen
Wyszyńska, J., Łuszczki, E., Seeman, T., Simonetti, G. D., Nyankovska, О. S., Wójcik, M., Kozioł-Kozakowska, A., Peletidi, A., Mazur, A., Pitti, J. Á., et al. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004052 · Cited by 2
Metadata
- Authors
- McCrindle, B. W., Urbina, E. M., Dennison, B. A., Jacobson, M. S., Steinberger, J., Rocchini, A. P., Hayman, L. L., & Daniels, S. R.
- Affiliations
- Hospital for Sick Children (CA)
- ORCID
- Venue
- Circulation
- Published
- 2007-04-10
- Volume
- 115
- Issue
- 14
- Pages
- 1948-1967
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2070344375
- Cited by
- 418
- References
- 153
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 8 · 2020: 19 · 2019: 11 · 2018: 7 · 2017: 12 · 2016: 18 · 2015: 23 · 2014: 26 · 2013: 32 · 2012: 36
- FWCI
- 53.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- familial hypercholesterolemia, severe hypercholesterolemia, lipid-lowering therapy, statins, early atherosclerosis, children and adolescents, patient selection, treatment monitoring
- MeSH terms
- Contraindications, Adolescent, Adult, Age Factors, Anticholesteremic Agents, Hypolipidemic Agents, Arteriosclerosis, Child, Child, Preschool, Cholesterol, Dietary, Clinical Trials as Topic, Combined Modality Therapy, Dietary Fats, Exercise Therapy, Female, Humans, Hyperlipoproteinemia Type II, Hyperlipoproteinemias, Infant, Cholesterol, LDL, Male, Phytotherapy, Middle Aged, Obesity, Risk Factors, Ultrasonography, HIV Infections, HIV Protease Inhibitors, Age of Onset, Disease Progression, Diet, Fat-Restricted, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Metabolic Syndrome, Diabetes Complications, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review